|
3-[(6,7-Dimethoxy-4-quinazolinyl)amino]-phenol
Inhibitor of IgE-mediated mast cell responses. Tau-Tubulin Kinase 1 inhibitor, phosphorylated TTBK1 KD = 0.46 µM, nonphosphorylated TTBK1 KD = 0.24 µM.
REarranged during Transfection (RET) kinase inhibitor, IC50 = 5 nM, KDR (VEGFR2) kinase inhibitor, IC50 = 66 nM
OTAVAchemicals Catalogue Number: 7015070102
CAS Registry Number: 211555-08-7
Purity: 97% (HPLC)
|
Read more...
|
2-({2-[(3-fluorophenyl)amino]pyrimidin-4-yl}amino)benzoic acid
JNK inhibitor (IC50 = 28 nM)
Chemical Formula: C17H13FN4O2
Molecular Weight: 324.3172
OTAVAchemicals Catalogue Number: 6543537
CAS Registry Number: 929007-58-9
Purity: 95% (HPLC)
|
Read more...
|
3-[5-[4-(2-hydroxy-2-methyl-1-oxopropyl)-1-piperazinyl]-2-(trifluoromethyl)phenyl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
A potent, ATP-binding site targeting and reversible inhibitor of GSK-3, JAK3, PKCa and PKC (IC50 = 3, 8, 13 and 68 nM, respectively) with excellent selectivity over 40-kinases, including JAK1, JAK2 and Tyk2 (IC50 = 1.017, 2.55 and 8.055 µM, respectively). Shown to efficiently block interleukin stimulated STAT5 phosphorylation and T cell costimulation (IC50 = 0.525, 1.294 and 0.689 µM in IL15-MO7, IL2-CTLL and TCR/CD28-Jurkat cells, respectively)
OTAVAchemicals Catalogue Number: 7070707149
CAS Registry Number: 1260181-14-3
Purity: 97% (HPLC)
|
Read more...
|
5-[(5-Nitro-2-thiazolyl)thio]-1,3,4-thiadiazol-2-amine (Halicin)
A selective inhibitor of c-Jun N-terminal kinase (JNK) (IC50 = 0.7 µM)
OTAVAchemicals Catalogue Number: 7070707069
CAS Registry Number: 40045-50-9
Purity: 95%+ (HPLC)
|
Read more...
|
(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylethyl]-2-propenamide
A potent antitumor agent (in vitro IC50 = 5.6 and 3.7 µM)
OTAVAchemicals Catalogue Number: 7070707057
CAS Registry Number: 857064-38-1
Purity: 95%+ (HPLC)
|
Read more...
|
4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol
JAK3 inhibitor, IC50 = 78 µM
OTAVAchemicals Catalogue Number: 7015070103
CAS Registry Number: 202475-60-3
Purity: 97% (HPLC)
|
Read more...
|
|
|
|
|